Nicorette Freshmint (Nicotine)

Nicotine, the active ingredient in Nicorette Freshmint, is a nicotine replacement therapy presented as an oromucosal product for use in adults seeking to quit smoking. It helps reduce cravings and withdrawal symptoms associated with nicotine dependence. It is intended for short‑term use as part of a comprehensive quit‑smoking program that includes behavioral support.

GNH USA supplies Nicorette Freshmint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Nicorette Freshmint is used in nicotine replacement therapy to aid smoking cessation and manage withdrawal. Smoking cessation: helps adult smokers gradually reduce nicotine dependence and quit tobacco use. Nicotine withdrawal relief: alleviates cravings, irritability, and other symptoms during the quitting process. Tobacco dependence: supports reduction of daily nicotine intake.

Nicorette Freshmint may cause a range of adverse reactions, most of which are mild and transient. Common Side Effects: - Mouth irritation or soreness - Throat irritation - Nausea - Hiccups - Dizziness - Headache Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Chest pain - Irregular heartbeat - Severe mouth ulceration - Difficulty breathing

When considering Nicorette Freshmint, several precautions should be observed to ensure safe use. Cardiovascular assessment: evaluate patients with recent heart attack or unstable angina before use. Concurrent nicotine products: avoid using other nicotine replacement therapies simultaneously to prevent overdose. Pregnancy and lactation: discuss risks with a healthcare professional before initiating therapy. Age restriction: not recommended for children under 18 years. Store at room temperature: keep in original packaging, protect from moisture and heat.

Nicotine can interact with other medicines, influencing their effects or increasing adverse reactions. Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may cause hypertensive crisis when combined with nicotine. - Other nicotine replacement products: risk of nicotine toxicity from additive dosing. Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., methoxsalen): may increase nicotine plasma levels. - Beta‑blockers: nicotine‑induced tachycardia may be masked, requiring monitoring. - Selective serotonin reuptake inhibitors (SSRIs): may enhance nicotine‑related side effects such as nausea.